Mary C. Clouser - Concepedia

Author

Mary C. Clouser

Naval Health Research Center ORCID

Also Known As

Jaime L. Horton, M C Clouser, M. CLOUSER, M. Clouser, Mary C Clouser, Mary C. Clouser, Mary Clouser

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Naval Health Research Center University of Arizona Leidos (United States)The University of Texas MD Anderson Cancer Center SWOG Cancer Research Network

About

Mary C. Clouser is an author at Naval Health Research Center specializing in medicine, injury prevention, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	397
2	Health Sciences	5	5	142
3	Arts	1	1	22
4	Social Sciences	1	1	14
5	Behavioral Health	1	1	26

Mary C. Clouser

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Phase III Trial of Ursodeoxycholic Acid To Prevent Colorectal Adenoma Recurrence David S. Alberts, Marı́a Elena Martı́nez, Lisa M. Hess, JNCI Journal of the National Cancer Institute	2005	248
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival David S. Alberts, Christian Marth, Ronald D. Alvarez, Gynecologic Oncology Progression-free SurvivalMedicineCancer ManagementGynecologyFirst-line Treatment	2008	128
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200) David S. Alberts, Pengfei Liu, Sharon P. Wilczynski, Gynecologic Oncology MedicineMetronomic TherapyGynecologyPathologyLiposomal Doxorubicin	2007	117
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211) David S. Alberts, P. Y. Liu, Sharon P. Wilczynski, International Journal of Gynecological Cancer	2007	69
Effect of non‐steroidal anti‐inflammatory drugs on non‐melanoma skin cancer incidence in the SKICAP‐AK trial Mary C. Clouser, Denise J. Roe, Janet A. Foote, Pharmacoepidemiology and Drug Safety	2009	64
Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer Setsuko K. Chambers, Mary C. Clouser, Amanda F. Baker, Clinical Cancer Research	2010	55
Major deployment-related amputations of lower and upper limbs, active and reserve components, U.S. Armed Forces, 2001-2017. Shawn Farrokhi, Katheryne Perez, Susan L. Eskridge, PubMed AmputationLimb ReconstructionMajor AmputationsLower Limb TraumaMajor Deployment-related Amputations	2018	39
Health-related quality of life among US military personnel injured in combat: findings from the Wounded Warrior Recovery Project Susan I. Woodruff, Michael R. Galarneau, Cameron T. McCabe, Quality of Life Research Quality Of LifeLife AssessmentUs Military PersonnelMilitary ContextHealth-related Quality	2018	36
Low back pain, mental health symptoms, and quality of life among injured service members. Jessica R. Watrous, Cameron T. McCabe, Gretchen Jones, Health Psychology	2020	34
Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer Setsuko K. Chambers, H.‐H. Sherry Chow, Mike F. Janicek, Clinical Cancer Research	2012	32

Page 1